Novo Nordisk partners with OpenAI in weight loss drug race ...Middle East

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday that it would use AI to analyze complex datasets, identify promising drug candidates...

Hence then, the article about novo nordisk partners with openai in weight loss drug race was published today ( Tuesday 14/04/2026 - 08:50 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk partners with OpenAI in weight loss drug race )

Also on site :

• Subnautica 2 Steam change suggests Krafton might be out as its publisher following long legal battle and reinstatement of studio leader
• Toilet tech is the next frontier of health data — but it might mean putting a camera on your bowl
• iPhone Fold To Give Samsung & Others A Huge Wake-Up Call; New Data Shows Its Launch Will Switch Foldable Smartphone Dynamics Of One Market